Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and BeyondWolfgang Löscher(University of Veterinary Medicine Hannover, Foundation), Henrik Klitgaard(UCB Pharma (Belgium))CNS DrugsOctober 17, 201610.1007/s40263-016-0384-xCited by 176SaveCiteExport RISWatch citationsRelated PapersBlood-brain barrier active efflux transporters: ATP-binding cassette gene family|NeuroRx|2004|849